T0	Participants 32 53	multi-centre studies.
T1	Participants 107 145	West Germany and involving 80 patients
T2	Participants 229 257	serious systemic infections.
T3	Participants 597 672	large collaborative study involving 15 centres, 254 patients were enrolled.